4
Changes in Ownership
AbbVie Inc. Filed Acc 0001179110-22-003076
EVP, Chief Strategy Officer sold 83,960 shares at $155.00 ($13,013,800)
- EVP, Chief Strategy Officer acquired 83,960 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gosebruch Henry O · EVP, Chief Strategy Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-16 | Exercise or conversion : show line 1 in the form | +83,960 | $54.86 | $4,606,046 | 100,583 | D |
| 2022-05-16 | Sale : show line 2 in the form | −83,960 | $155.00 | $13,013,800 | 16,623 | D |
| Open-market sales · 83,960 sh · avg $155.00 · $13,013,800 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2022-05-16 | Exercise or conversion : show line 3 in the form Option (Right to Buy) | −83,960 | $54.86 | $4,606,046 | $54.86 | 2026-02-17 | 83,960 | 0 | D |
Loading xslF345X03/edgar.xml…